Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

The NetherlandsBack to the Netherlands

Clinical trials in Drachten

13 clinical trials in Drachten, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Drachten at a glance
13
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

13 trials in Drachten

Open in trial search

Triple negative breast cancer

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Intensive care

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Region Hovedstaden

Chronic kidney disease

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Universitair Medisch Centrum Groningen

Plasma cell myeloma

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Prolymphocytic leukaemia+2

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Colorectal cancer metastatic

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Hormone-refractory prostate cancer

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cabazitaxel
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Prostate cancer metastatic

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Merck Sharp & Dohme LLC

Gestational diabetes

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years
  • Substances:Metformin Hydrochloride
  • Sponsor:Bethesda Diabetes Research Center B.V.

Hormone receptor positive HER2 negative breast cancer

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:BOOG Study Center B.V.

Breast cancer stage III+2

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BOOG Study Center B.V.

Colon cancer stage III+1

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Drachten

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on breast cancer treatment optimization, including evaluation of targeted therapies and chemotherapy de-escalation approaches. Research includes innovative trials for HER2-positive breast cancer and hormone receptor-positive advanced cases.

  • Breast Cancer Treatment Optimization
  • Advanced Cancer Therapies
  • Targeted Treatment Strategies

Additional investigations include studies on colon cancer recurrence prevention and novel approaches for esophagogastric cancer treatment.

02 Hematologic Oncology

Comprehensive research examining treatment protocols for multiple myeloma and non-Hodgkin lymphoma. Studies focus on evaluating targeted anti-cancer drugs and innovative treatment scheduling approaches.

  • Blood Cancer Therapeutics
  • Treatment Duration Studies
  • Drug Response Assessment

Investigations include analysis of treatment-free intervals and continuous therapy comparisons.

03 Metabolic and Renal Research

Critical studies addressing gestational diabetes mellitus management and chronic kidney disease treatments. Research examines innovative therapeutic approaches including the use of metformin for pregnancy-related diabetes.

  • Kidney Disease Management
  • Gestational Diabetes Treatment
  • Cardiovascular Outcomes

Studies include long-term follow-up of both maternal and child health outcomes.

Back to the NetherlandsAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.